Nuzenio

Veraxa Biotech Advances

Veraxa Biotech Advances news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

VERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:46 GMTVERAXA Biotech Advances VXA-222 bsADC Program and Expands Patent Portfolio - citybuzz -citybuzz - · Fri, 07 Aug 2026 00:22:56 GMTVERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 18:30:00 GMTVERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:20 GMTVERAXA Biotech (VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration - NewMediaWireNewMediaWire · Mon, 27 Jul 2026 19:43:56 GMTVeraxa Biotech (VRXA) moves bispecific ADC VXA-222 program forward - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMTVeraxa Advances Bispecific ADC Candidate VXA-222 Following OmniAb Discovery Milestone - BioPharm InternationalBioPharm International · Mon, 27 Jul 2026 07:00:00 GMTVERAXA’s VXA-222 Uses One Molecule to Address Two Tumor Antigens - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 00:18:46 GMTVERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -
Fri, 07 Aug 2026 00:22:56 GMTVERAXA Biotech Advances VXA-222 bsADC Program and Expands Patent Portfolio - citybuzz -
Thu, 06 Aug 2026 18:30:00 GMTVERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies - Yahoo Finance
Thu, 06 Aug 2026 00:24:20 GMTVERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio - citybuzz -
Mon, 27 Jul 2026 19:43:56 GMTVERAXA Biotech (VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration - NewMediaWire
Mon, 27 Jul 2026 07:00:00 GMTVeraxa Biotech (VRXA) moves bispecific ADC VXA-222 program forward - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Veraxa Biotech Advances.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.